Free Trial
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

Hemostemix logo
C$0.14 +0.01 (+3.70%)
As of 03:34 PM Eastern

About Hemostemix Stock (CVE:HEM)

Key Stats

Today's Range
C$0.14
C$0.15
50-Day Range
C$0.08
C$0.15
52-Week Range
C$0.04
C$0.43
Volume
272,977 shs
Average Volume
408,721 shs
Market Capitalization
C$20.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

HEM Stock News Headlines

Hemostemix Closes $469,366 Private Placement
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
See More Headlines

HEM Stock Analysis - Frequently Asked Questions

Hemostemix's stock was trading at C$0.12 at the beginning of 2025. Since then, HEM shares have increased by 16.7% and is now trading at C$0.14.

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Golden Share Resources (GSH), Nuvilex (PMCB), Algernon Pharmaceuticals (AGNPF), Defense Metals (DFMTF) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:HEM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.00 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
10.77
Book Value
C($0.10) per share
Price / Book
-1.41

Miscellaneous

Free Float
N/A
Market Cap
C$20.40 million
Optionable
Not Optionable
Beta
0.20
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:HEM) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners